British Journal of Cancer

<strongg>British Journal of Cancer (BJC) </strong>exists to serve the needs of this diverse community, providing a forum for prompt communication of original and innovative research findings that have relevance to understanding the etiology of cancer and to improving the treatment and survival of patients. BJC works with a distinguished team of international experts to ensure the highest standards of selection and review. All relevant papers are carefully considered. Once accepted, papers are published rapidly in print and online.<br>
<a href="http://www.nature.com/bjc/index.html&quot; target="_blank">www.nature.com/bjc</a&gt;

Title abbreviation
Br J Cancer
Cover image
Image

A medical nutriment has supportive value in the treatment of colorectal cancer

Avemar (MSC) is a medical nutriment of which preclinical and observational clinical studies suggested an antimetastatic activity with no toxicity. This open-label cohort trial has compared anticancer treatments plus Avemar (9 g once daily) vs anticancer treatments alone in colorectal patients, enrolled from three oncosurgical centres; cohort allocation was on the basis of patients’ choice.

Search publications